| | | | | | | |
 | MODERNA, INC. | -2.60% | -14.65% | -42.48% | -61.09% | 990.30% | 57 154 |
| IQVIA HOLDINGS INC. | 0.08% | -2.76% | -15.28% | -6.87% | 52.51% | 44 579 |
 | LONZA GROUP AG | -1.74% | -1.09% | -25.95% | -24.70% | 61.93% | 43 637 |
| SEAGEN INC. | 1.53% | 0.90% | 11.04% | 8.59% | 116.24% | 31 662 |
| ALNYLAM PHARMACEUTICALS, INC. | -3.35% | -7.65% | 27.36% | 9.64% | 162.74% | 25 922 |
| ICON PUBLIC LIMITED COMPANY | -1.65% | -3.13% | -24.55% | -5.24% | 48.49% | 19 051 |
| BIO-TECHNE CORPORATION | -1.83% | -6.54% | -31.41% | -25.44% | 83.00% | 13 921 |
 | HANGZHOU TIGERMED CONSULTING CO., LTD. | -1.26% | -0.50% | -19.01% | -29.68% | 77.59% | 12 431 |
| PHARMARON BEIJING CO., LTD. | -1.21% | -4.69% | -23.91% | -44.36% | 153.99% | 11 815 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | -1.16% | -2.79% | -42.25% | -48.23% | 66.44% | 11 067 |
| QIAGEN N.V. | -0.65% | -4.80% | -15.29% | -10.68% | 35.25% | 10 720 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | 0.01% | 0.20% | 7.43% | 25.35% | 287.87% | 10 585 |
| UNITED THERAPEUTICS CORPORATION | 0.45% | 3.38% | 3.87% | 11.63% | 174.31% | 10 216 |
 | GENSCRIPT BIOTECH CORPORATION | -1.82% | -4.94% | -21.88% | -22.33% | 50.22% | 7 261 |
| SYNEOS HEALTH, INC. | -1.37% | -4.07% | -35.64% | -24.98% | 29.42% | 6 783 |
| | | | | | | |
| | Durchschnitt | -1.10% | -3.54% | -16.53% | -16.56% | 159.35% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | -1.21% | -4.73% | -17.42% | -19.87% | 255.39% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
